Research and Development

Welcome to genomIQ, the research and development arm of Integrity Laboratories.

genomIQ is a project-in-residence program that accelerates emerging laboratory technologies from concept to commercial. As an applied science incubator, genomIQ is focused on bringing meaningful innovation to life in the form of advanced diagnostic applications.

Founded upon the principals of design thinking, genomIQ approaches each project with a focus on novel healthcare applications which lead to enhanced patient outcomes.

Design thinking is all about
building unmatched user experiences with innovation
-Nisarg Mehta

For Collaboration Inquiries, Please CLICK HERE

Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.

Please direct all inquiries to for immediate review.

Click Here for CDC recommendations for Identifying Monkeypox.

FDA Authorization Letter   |   FDA EUA Summary

CARES Act Statement